![Jeff Sharman Profile](https://pbs.twimg.com/profile_images/1479920064623112194/ZW13Skwh_x96.jpg)
Jeff Sharman
@jeff_sharman
Followers
3K
Following
2K
Statuses
2K
Harvard/Stanford trained community practice Heme/Onc - Director of Hematology Research US Oncology - challenging white collar traditions with blue collar moxie
Eugene, OR
Joined June 2013
@themarketswork @RandPaul I grew up in the shadow of plum island - this is a useful read from the pre-Covid era detailing how pathogens can escape labs. No politics involved as this was written 20 years ago
0
0
1
RT @VJHemOnc: In this podcast, @jeff_sharman, Jennifer Brown, Alexey Danilov, @niravshahmd, and @chanyooncheah discuss CLL highlights from…
0
1
0
@AaronGoodman33 Amazingly effective video I highly recommend the 1hr of your life - eye opening on the inner workings of supplements
0
0
1
RT @RepGregMurphy: The expressed purpose of the ACA is to drive physicians out of private practice into employment with the ultimate goal o…
0
60
0
@ClayReedMD @VincentRK @eaonc And for “me too” drugs: Consider acalabrutinib and zanubrutinib relative to ibrutinib. “Me too?” Or meaningfully differentiated? Many times follow on drugs offer subtle differences that we can utilize on behalf of our unique patients.
2
2
6
RT @JahangirAsgha10: I do find it ironic that Congress is giving themselves a cost-of-living increase, but has continued to decrease Medica…
0
102
0
@Fishy_fun7 @RenoHemonc @VPrasadMDMPH Ask any AML doc or patient who has had this therapy and you will have your answer - these are an amazing therapies that will change what it means to have this sort of cancer. While we grieve for any patient for whom it doesn't work, it is huge progress for many more.
1
0
2
RT @OncLive: Pirtobrutinib Improves PFS in Previously Treated CLL/SLL @jeff_sharman @ASH_hematology #ASH24 #leusm #oncology
0
1
0
@KMirza @HemOncFellows @ASH_hematology @sanamloghavi @UMHemOncFellows @UMichPath Hereditary rectangulocytosis
1
1
3